Condition

Leukemia, Acute Myelogenous (2)

AML (1)

Acute Myelogenous Leukemia (1)

Acute Myeloid Leukemia (1)

Bone Marrow Transplant (1)

Leukemia, Acute Myeloid (1)

Leukemia, Myeloid, Acute (1)

Myelogenous Leukemia, Acute (1)

Myeloid Leukemia, Acute (1)

Overall Status

Active, not recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 1 (1)

phase 3 (1)

Sponsor

Actinium Pharmaceuticals (1)

Alison Sehgal, MD, MS (1)

Collaborator

Intervention

conventional care (1)

etoposide (1)

hct (1)

hydroxychloroquine (1)

iomab-b (1)

mitoxantrone (1)

Study Documents

Intervention Type

drug (2)

procedure (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

leukemia, acute myelogenous

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional

Active, not recruiting

Acute Myeloid Leukemia
+8 more

Iomab-B
+2 more

Gilbert, Arizona
+23 more

Feb 22, 2022

Leukemia, Acute Myelogenous Trial in Pittsburgh (Hydroxychloroquine, Mitoxantrone, Etoposide)

Terminated

Leukemia, Acute Myelogenous

Hydroxychloroquine
+2 more

Pittsburgh, Pennsylvania

University of Pittsburgh Cancer Institute - Hillman Cancer Cente

Feb 21, 2018